My Oracle Support Banner

Erroneous Study Drug ‘Substance Name, Strength and Unit’ Details After Case Unblinding (Doc ID 2407107.1)

Last updated on APRIL 26, 2021

Applies to:

Oracle Argus Safety - Version 8.1.1 and later
Information in this document applies to any platform.


Oracle Argus Safety Version : 8.1.1 and later

Incorrect Study Drug ‘Substance Name, Strength and Unit’ details are displayed after Case Unblinding

Substance Name details of Study Drug are not consistent with Study Drug Ingredients.

For blinded studies with multiple study drugs configured in the study, Blinded case shows Substance Name details from first Study Drug configured in Argus Console for the study.

Upon unblinding and selecting a study drug that is not the first study drug configured in the study, the Substance Name details are added to the details already present instead of being substituted.

 The issue can be reproduced at will with the following steps.







To view full details, sign in with your My Oracle Support account.

Don't have a My Oracle Support account? Click to get started!

In this Document

My Oracle Support provides customers with access to over a million knowledge articles and a vibrant support community of peers and Oracle experts.